课题基金 / 基金详情

项目摘要

项目成果

DAVID B SCHAUER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Idiopathic inflammatory bowel disease (IBD) is a debilitating condition with no known etiology. The pathogenesis of IBD has been studied using targeted gene mutant (knockout) mice that develop chronic intestinal inflammation, which resembles human IBD. It has been shown in several of these knockout mouse models, including T cell receptor alpha beta (TCR alpha beta), interleukin-2 (IL-2), and IL-10 knockout mice, that germ-free conditions protect against the development of IBD. It does not appear that resident intestinal microbiota are sufficient to trigger disease in these animals, but experimental infection with an emerging group of murine bacterial pathogens called enterohepatic Helicobacter species is sufficient to cause IBD. To better understand the pathogenesis of disease in these models, we propose to elucidate the mechanisms by which enterohepatic Helicobacter species cause IBD in knockout mice. Although the adaptive immune system is important in the pathogenesis of IBD, knockout mice lacking adaptive immunity are also susceptible to Helicobacter-associated IBD. For this reason, our proposed studies focus on interactions between enterohepatic Helicobacter species and the innate immune system. Studies will be carried out with Helicobacter hepaticus, the most well characterized enterohepatic Helicobacter species. We and our collaborators have recently determined the complete genome sequence of H. hepaticus ATCC 51449. Taking advantage of the genome sequence, we will identify and characterize candidate bacterial virulence determinants, and generate isogenic mutant strains to test in culture with murine intestinal epithelial cell monolayers and murine macrophages, and in vivo with selected knockout mouse models. These studies will test the hypothesis that discrete bacterial virulence determinants in enterohepatic Helicobacter species elicit proinflammatory responses from the innate immune system, which in the absence of a properly regulated adaptive immune system, lead to IBD. It is hoped that these studies will lead to the development of new strategies for the treatment and the prevention of IBD.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.
肝螺杆菌感染会引发 T 细胞受体 Alphata 突变小鼠的炎症性肠病。
DOI: --
发表时间: 2000
期刊: Comparative medicine
影响因子: 0.8
作者: [Chin,EY, Dangler,CA, Fox,JG, Schauer,DB]
通讯作者: Schauer,DB
In Vivo Role of Nitric Oxide in Muscosal Inflammation and Cancer
Core--Environmental Systems and Health Research
In Vivo Role of NO in Mucosal Inflammation and Cancer
H HEPATICUS--PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE
海外基金